Literature DB >> 34472210

Endoscopic submucosal dissection versus endoscopic mucosal resection for rectal carcinoid tumor. A meta-analysis and meta-regression with single-arm analysis.

Jie Ning Yong1, Xiong Chang Lim1, Kameswara Rishi Yeshayahu Nistala1, Lincoln Kai En Lim1, Grace En Hui Lim2, Jingxuan Quek1, Hui Yu Tham3, Neng Wei Wong3, Ker-Kan Tan3, Choon Seng Chong1,3.   

Abstract

OBJECTIVE: As there has been so far no consensus on the best endoscopic resection technique, a meta-analysis was conducted to compare the efficacy and safety of endoscopic submucosal dissection (ESD) and endoscopic mucosal resection (EMR) for treating rectal carcinoid tumors.
METHODS: MEDLINE and EMBASE databases were searched for articles on the treatment of rectal carcinoid tumors using ESD vs EMR published up to October 2020 for outcomes including en bloc and complete resection, margin involvement, procedure time, requirement for additional surgery, bleeding, perforation and recurrence. Risk ratio and weighted mean differences were used for a DerSimonian and Laird random effects pairwise meta-analysis. Single-arm meta-analyses of proportions and random effects meta-regression analysis were also conducted.
RESULTS: Twenty-two studies involving 1360 rectal carcinoid tumors were included, in which 655 and 705 rectal carcinoid tumors were resected with ESD and EMR, respectively. The resection efficacy of ESD was comparable to that of EMR for tumors <10 mm. However, there were a significantly higher complete resection rate, and lower rates of vertical margin involvement and requirement for additional surgery using ESD than using EMR for tumors ≤20 mm. ESD had a longer procedure time and an increased likelihood of bleeding than EMR.
CONCLUSIONS: ESD is more effective in providing a curative treatment for rectal carcinoid tumors ≤20 mm in size as ESD can achieve a higher complete resection rate with lower vertical margin involvement than EMR. While they are suitable for treating rectal carcinoid tumors <10 mm as both techniques provide similar efficacy.
© 2021 Chinese Medical Association Shanghai Branch, Chinese Society of Gastroenterology, Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  endoscopic mucosal resection; endoscopic submucosal dissection; meta-analysis; rectal carcinoid neoplasms

Mesh:

Year:  2021        PMID: 34472210     DOI: 10.1111/1751-2980.13048

Source DB:  PubMed          Journal:  J Dig Dis        ISSN: 1751-2972            Impact factor:   2.325


  4 in total

Review 1.  Clinical and Molecular Characteristics of Rare Malignant Tumors of Colon and Rectum.

Authors:  Alessandro Ottaiano; Mariachiara Santorsola; Francesco Perri; Ugo Pace; Bruno Marra; Marco Correra; Francesco Sabbatino; Marco Cascella; Nadia Petrillo; Monica Ianniello; Marika Casillo; Gabriella Misso; Paolo Delrio; Michele Caraglia; Guglielmo Nasti
Journal:  Biology (Basel)       Date:  2022-02-08

Review 2.  Endoscopic treatment for rectal neuroendocrine tumor: which method is better?

Authors:  Seung Min Hong; Dong Hoon Baek
Journal:  Clin Endosc       Date:  2022-07-11

Review 3.  Diagnosis, treatment, and current concepts in the endoscopic management of gastroenteropancreatic neuroendocrine neoplasms.

Authors:  Giuseppe Iabichino; Milena Di Leo; Monica Arena; Giovanni Giuseppe Rubis Passoni; Elisabetta Morandi; Francesca Turpini; Paolo Viaggi; Carmelo Luigiano; Luca De Luca
Journal:  World J Gastroenterol       Date:  2022-09-14       Impact factor: 5.374

Review 4.  Molecular factors, diagnosis and management of gastrointestinal tract neuroendocrine tumors: An update.

Authors:  Efstathios Theodoros Pavlidis; Theodoros Efstathios Pavlidis
Journal:  World J Clin Cases       Date:  2022-09-26       Impact factor: 1.534

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.